162 related articles for article (PubMed ID: 31372893)
1. Intrahepatic Cholangiocarcinoma.
El-Diwany R; Pawlik TM; Ejaz A
Surg Oncol Clin N Am; 2019 Oct; 28(4):587-599. PubMed ID: 31472907
[TBL] [Abstract][Full Text] [Related]
2. Peribiliary glands: development, dysfunction, related conditions and imaging findings.
Matsubara T; Kozaka K; Matsui O; Nakanuma Y; Uesaka K; Inoue D; Yoneda N; Yoshida K; Kitao A; Yokka A; Koda W; Gabata T; Kobayashi S
Abdom Radiol (NY); 2020 Feb; 45(2):416-436. PubMed ID: 31707436
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the degree of abdominal wall movement and the image quality of contrast-enhanced MRI: semi-quantitative study especially focused on the occurrence of transient severe motion artifact.
Ikeno H; Kobayashi S; Kozaka K; Ogi T; Inoue D; Yoneda N; Yoshida K; Ohno N; Gabata T; Kitao A
Jpn J Radiol; 2020 Feb; 38(2):165-177. PubMed ID: 31691090
[TBL] [Abstract][Full Text] [Related]
4. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.
King MJ; Hectors S; Lee KM; Omidele O; Babb JS; Schwartz M; Tabrizian P; Taouli B; Lewis S
Cancer Imaging; 2020 Jul; 20(1):43. PubMed ID: 32620153
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapies for intrahepatic cholangiocarcinoma.
Kelley RK; Bridgewater J; Gores GJ; Zhu AX
J Hepatol; 2020 Feb; 72(2):353-363. PubMed ID: 31954497
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review.
Minamiguchi K; Irizato M; Uchiyama T; Taiji R; Nishiofuku H; Marugami N; Tanaka T
Eur Radiol; 2023 Dec; 33(12):8764-8775. PubMed ID: 37470828
[TBL] [Abstract][Full Text] [Related]
7. Imaged periductal infiltration: Diagnostic and prognostic role in intrahepatic mass-forming cholangiocarcinoma.
Okumura K; Kozaka K; Kitao A; Yoneda N; Ogi T; Ikeda H; Gabata T; Kobayashi S
Eur J Radiol Open; 2024 Jun; 12():100554. PubMed ID: 38390438
[TBL] [Abstract][Full Text] [Related]
8. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma-A Scoping Review.
Lederer AK; Rasel H; Kohnert E; Kreutz C; Huber R; Badr MT; Dellweg PKE; Bartsch F; Lang H
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764207
[TBL] [Abstract][Full Text] [Related]
10. Integration analysis of miRNA-mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma.
Liu L; Shi Y; Zhang P; Zhang X
Sci Rep; 2023 May; 13(1):8362. PubMed ID: 37225858
[TBL] [Abstract][Full Text] [Related]
11. The expression profiles of circular RNAs and competing endogenous RNA networks in intrahepatic cholangiocarcinoma.
Liang Z; Liu L; Guo X; Wu X; Yu YL; Yu Z; Hu X; Zhang X; Wang J
Front Cell Dev Biol; 2022; 10():942853. PubMed ID: 36274844
[No Abstract] [Full Text] [Related]
12. Inflammation-Induced Tumorigenesis and Metastasis.
Hibino S; Kawazoe T; Kasahara H; Itoh S; Ishimoto T; Sakata-Yanagimoto M; Taniguchi K
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063828
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma.
Zhang C; Zhang B; Meng D; Ge C
Cancer Cell Int; 2019; 19():352. PubMed ID: 31889904
[TBL] [Abstract][Full Text] [Related]
14. Early detection of intrahepatic cholangiocarcinoma.
Hamaoka M; Kozaka K; Matsui O; Komori T; Matsubara T; Yoneda N; Yoshida K; Inoue D; Kitao A; Koda W; Gabata T; Kobayashi S
Jpn J Radiol; 2019 Oct; 37(10):669-684. PubMed ID: 31372893
[TBL] [Abstract][Full Text] [Related]
15. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
16. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
Seo N; Kim DY; Choi JY
AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
[TBL] [Abstract][Full Text] [Related]
17. Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation.
Mar WA; Shon AM; Lu Y; Yu JH; Berggruen SM; Guzman G; Ray CE; Miller F
Abdom Radiol (NY); 2016 Mar; 41(3):553-67. PubMed ID: 26847022
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation.
Lo EC; N Rucker A; Federle MP
Semin Radiat Oncol; 2018 Oct; 28(4):267-276. PubMed ID: 30309637
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinicopathological characteristics between patients with occupational and non-occupational intrahepatic cholangiocarcinoma.
Hamano G; Kubo S; Takemura S; Tanaka S; Shinkawa H; Kinoshita M; Ito T; Yamamoto T; Wakasa K; Shibata T
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):389-96. PubMed ID: 27062258
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
